Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Non-Current Deferred Tax Liability of $1.9 million for Q1 2026, up 2007.95% year-over-year from $88000.0 in Q1 2025, and up 6.92% quarter-over-quarter from $1.7 million in Q4 2025.
Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Non-Current Deferred Tax Liability for 17 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability rose 2007.95% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 2007.95% YoY), while the FY2025 annual figure was $1.7 million, up 1941.18% from the prior year.
- Non-Current Deferred Tax Liability improved to $1.9 million in Q1 2026 per LMAT's latest filing, from $1.7 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $2.1 million in Q3 2025 and bottomed at $60000.0 in Q3 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $403117.6 across 5 years, with a median of $88000.0 in 2025.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability sank 50.82% — and 2026, when it soared 2007.95%.
- Lemaitre Vascular's Non-Current Deferred Tax Liability stood at $69000.0 in 2022, then soared by 55.07% to $107000.0 in 2023, then fell by 20.56% to $85000.0 in 2024, then soared by 1941.18% to $1.7 million in 2025, then advanced by 6.92% to $1.9 million in 2026.
- Business Quant data shows LMAT's Non-Current Deferred Tax Liability at $1.9 million in Q1 2026, $1.7 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 95,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 85,000.00 |
| Dec 31, 2024 | 85,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Mar 31, 2024 | 114,000.00 |